Consolidated Balance Sheet (Unaudited) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 400	$ 289
Trade accounts and other receivables	940	1,002
Allowance for doubtful accounts	(10)	(6)
Trade accounts and other receivables – net	930	996
Inventories	105	125
Other current assets and deferred charges	130	170
Total current assets	1,565	1,580
Investments	5,179	6,235
Property, plant, and equipment	41,772	41,510
Accumulated depreciation and amortization	(12,631)	(12,310)
Property, plant, and equipment – net	29,141	29,200
Intangible assets – net of accumulated amortization	7,688	7,959
Regulatory assets, deferred charges, and other	1,056	1,066
Total assets	44,629	46,040
Current liabilities:
Accounts payable	359	552
Accrued liabilities	1,129	1,276
Long-term debt due within one year	628	2,140
Total current liabilities	2,116	3,968
Long-term debt	21,848	20,148
Deferred income tax liabilities	1,602	1,782
Regulatory liabilities, deferred income, and other	3,804	3,778
Contingent liabilities (Note 12)
Stockholders’ equity:
Preferred Stock	35	35
Common stock ($1 par value; 1,470 million shares authorized at March 31, 2020 and December 31, 2019; 1,248 million shares issued at March 31, 2020 and 1,247 million shares issued at December 31, 2019)	1,248	1,247
Capital in excess of par value	24,330	24,323
Retained deficit	(12,013)	(11,002)
Accumulated other comprehensive income (loss)	(205)	(199)
Treasury stock, at cost (35 million shares of common stock)	(1,041)	(1,041)
Total stockholders’ equity	12,354	13,363
Noncontrolling interests in consolidated subsidiaries	2,905	3,001
Total equity	15,259	16,364
Total liabilities and equity	$ 44,629	$ 46,040